Skip to main content

Watch Read Start Learn Tools

Sign In

Watch Read Start Learn ToolsSubscribe YouTube GitHub

Developers Digest

DEVDIGEST

Videos and open-source projects at the intersection of AI and development

Weekly AI dev insights. Free.

Watch

Videos
YouTube
Series
Weekly
News
Newsletter
Podcast

Read

Blog
Best Of
Topics
Tags
Glossary
Markets
RSS Feed

Start

Start Here
Agent Picker
Compare Tools
AI Pricing
Best AI Coding Tools
Best MCP Servers

Learn

Learning Paths
Courses
Guides
Claude Code Guide
Build MCP Servers
Snippets

Tools

Tools Directory
Developer Toolkit
Prompt Library
Token Counter
MCP Config
README Generator

More

About
Press Kit
Get the extension →
Partner With Us
Uses
Roadmap
Changelog
GitHub
Twitter/X

Watch

Videos
YouTube
Series
Weekly
News
Newsletter
Podcast

Read

Blog
Best Of
Topics
Tags
Glossary
Markets
RSS Feed

Start

Start Here
Agent Picker
Compare Tools
AI Pricing
Best AI Coding Tools
Best MCP Servers

Learn

Learning Paths
Courses
Guides
Claude Code Guide
Build MCP Servers
Snippets

Tools

Tools Directory
Developer Toolkit
Prompt Library
Token Counter
MCP Config
README Generator

More

About
Press Kit
Get the extension →
Partner With Us
Uses
Roadmap
Changelog
GitHub
Twitter/X

© 2026 DEVELOPERS DIGEST

ArriVent BioPharma, Inc. Revenue history | AVBP - Developers Digest

Watch Read Start Learn Tools

Sign In

Watch Read Start Learn ToolsSubscribe YouTube GitHub

Home
/Markets
/AVBP
/Revenue

← All companies

A

ArriVent BioPharma, Inc.

AVBP - CIK 0001868279

Market cap$1.41 B

Rank#2376

SEC filings144

Overview Market Cap Revenue Net Income Income Statement Balance Sheet Cash Flow SEC Filings

ArriVent BioPharma, Inc. revenue by year

No parsed revenue data available for ArriVent BioPharma, Inc. yet.

Revenue of similar companies

LLYEli Lilly and Company$1.072 T JNJJohnson & Johnson$573.98 B ABBVAbbVie Inc.$399.47 B MRKMerck & Co., Inc.$293.16 B AZNAstraZeneca PLC$286.27 B NVSNovartis AG$283.13 B

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.